Spots Global Cancer Trial Database for effectiveness
Every month we try and update this database with for effectiveness cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis | NCT01865201 | Nasopharyngeal ... Brain Necrosis | Edaravone Common fundamen... | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis | NCT01865201 | Nasopharyngeal ... Brain Necrosis | Edaravone Common fundamen... | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis | NCT01865201 | Nasopharyngeal ... Brain Necrosis | Edaravone Common fundamen... | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma | NCT03973125 | Circumscribed C... | conbercept | 12 Years - 90 Years | Sun Yat-sen University | |
| Effectiveness of Hospital Fit on Physical Activity of Hospitalised Patients | NCT05378724 | Cardiovascular ... Oncology Activation, Pat... | Hospital Fit 2.... | 18 Years - | Maastricht University Medical Center | |
| Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China | NCT01839630 | Carcinoma, Hepa... | Sorafenib (Nexa... | - | Bayer | |
| Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts | NCT05880628 | Bone Cysts | datas of medica... | - | Centre Hospitalier Universitaire de Saint Etienne | |
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| Whether it is More Appropriate to Spray Lugol's Solution From Cervical Esophagus to Esophagogastric Junction | NCT04224363 | Esophageal Squa... | staining from c... staining from e... | 18 Years - 80 Years | Shandong University | |
| Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma | NCT03973125 | Circumscribed C... | conbercept | 12 Years - 90 Years | Sun Yat-sen University | |
| Lenvatinib for Advanced Bone and Soft Tissue Sarcoma | NCT05617859 | Effectiveness Sexuality | Lenvatinib mesy... | 10 Years - 70 Years | Henan Cancer Hospital | |
| Study of BEBT-908 in Subjects With Advanced Hematological Tumors | NCT06082596 | Relapsed or Ref... Relapsed or Ref... | BEBT-908 for in... | 18 Years - 70 Years | BeBetter Med Inc | |
| Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan | NCT05399329 | Breast Cancer | Palbociclib Endocrine thera... | 20 Years - | Pfizer | |
| Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma | NCT06060080 | Lymphoma Multiple Myelom... | pegylated recom... | 18 Years - 65 Years | Chongqing University Cancer Hospital | |
| Effectiveness of Hospital Fit on Physical Activity of Hospitalised Patients | NCT05378724 | Cardiovascular ... Oncology Activation, Pat... | Hospital Fit 2.... | 18 Years - | Maastricht University Medical Center | |
| a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors | NCT05177666 | Feasibility Effectiveness Safety Targeted Molecu... | Targeted therap... | 18 Years - | The University of Hong Kong-Shenzhen Hospital | |
| Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma | NCT06060080 | Lymphoma Multiple Myelom... | pegylated recom... | 18 Years - 65 Years | Chongqing University Cancer Hospital | |
| Use of an Oxidized Regenerated Cellulose After Hepatic Surgery | NCT01436721 | Liver Neoplasms | Surgicel® absor... | 18 Years - 70 Years | Fudan University | |
| Antineoplastic Drugs in Elderly Patients | NCT05467189 | Cancer | Busulfan, Pacli... | 65 Years - 100 Years | Shandong University | |
| Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation | NCT06117371 | Advanced or Met... KRAS G12C Mutat... | BEBT-607Tablets | 18 Years - | BeBetter Med Inc | |
| Sorafenib in Elderly mRCC | NCT01728948 | Carcinoma, Rena... | Sorafenib (Nexa... | 65 Years - | Bayer | |
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| Study of BEBT-908 in Subjects With Advanced Hematological Tumors | NCT06082596 | Relapsed or Ref... Relapsed or Ref... | BEBT-908 for in... | 18 Years - 70 Years | BeBetter Med Inc | |
| The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy | NCT02771756 | Breast Cancer Lung Cancer | zhen qishen cap... zhen qishen cap... chemotherapy nutrition educa... | 18 Years - 70 Years | ChineseAMS | |
| Effectiveness of Intensive Smoking Cessation Interventions in Patients With Cancer | NCT04198688 | Tobacco Smoking Cancer Tobacco Cessati... | Intensive Smoki... | 18 Years - | Bispebjerg Hospital | |
| The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor | NCT02317224 | Thymectomy Myasthenia Grav... | "3-Hole" subxip... Trans sternal a... VATS approach | 18 Years - 75 Years | Tang-Du Hospital | |
| Endoscopic Sub-mucosal Dissection With the Nestis® Jet Injector System With a Bi-functional Catheter: First Prospective Trial | NCT01913223 | Barrett's Esoph... Intestinal Dysp... Esophageal Dysp... Colorectal Neop... | Nestis® jet inj... | 18 Years - | Hospices Civils de Lyon | |
| Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma | NCT03571282 | Circumscribed C... | conbercept | 15 Years - 90 Years | Sun Yat-sen University | |
| Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma | NCT03973125 | Circumscribed C... | conbercept | 12 Years - 90 Years | Sun Yat-sen University | |
| Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine | NCT03025711 | Breast Neoplasm... | 18 Years - 100 Years | Puerta de Hierro University Hospital | ||
| Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition | NCT04188990 | Pancreatitis, A... Crohn Disease Ulcerative Coli... Inflammatory Bo... Pancreatic Canc... Esophagus Cance... Gastric Cancer Colorectal Canc... | Nutritional die... By demand Usual current c... | 18 Years - | Hospital Galdakao-Usansolo | |
| Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer | NCT04385641 | Advanced Gastri... Gastroesophagea... | Cell infusion f... Cell infusion f... | 18 Years - 75 Years | Shandong Golden Brick Biotechnology Co., Ltd. | |
| Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer | NCT04385641 | Advanced Gastri... Gastroesophagea... | Cell infusion f... Cell infusion f... | 18 Years - 75 Years | Shandong Golden Brick Biotechnology Co., Ltd. | |
| Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan | NCT05399329 | Breast Cancer | Palbociclib Endocrine thera... | 20 Years - | Pfizer | |
| Antineoplastic Drugs in Elderly Patients | NCT05467189 | Cancer | Busulfan, Pacli... | 65 Years - 100 Years | Shandong University | |
| Whether it is More Appropriate to Spray Lugol's Solution From Cervical Esophagus to Esophagogastric Junction | NCT04224363 | Esophageal Squa... | staining from c... staining from e... | 18 Years - 80 Years | Shandong University | |
| Lenvatinib for Advanced Bone and Soft Tissue Sarcoma | NCT05617859 | Effectiveness Sexuality | Lenvatinib mesy... | 10 Years - 70 Years | Henan Cancer Hospital | |
| Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis | NCT00518557 | Hepatocellular ... | Transcatheter A... | 18 Years - 70 Years | Southeast University, China | |
| Lenvatinib for Advanced Bone and Soft Tissue Sarcoma | NCT05617859 | Effectiveness Sexuality | Lenvatinib mesy... | 10 Years - 70 Years | Henan Cancer Hospital | |
| Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma | NCT06060080 | Lymphoma Multiple Myelom... | pegylated recom... | 18 Years - 65 Years | Chongqing University Cancer Hospital | |
| Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts | NCT05880628 | Bone Cysts | datas of medica... | - | Centre Hospitalier Universitaire de Saint Etienne |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
